¿Cómo Podemos Ayudarle?
Puede haber opciones para ayudarle a cubrir los gastos de RITUXAN,
independientemente del tipo de seguro médico que posea.
Derivación a Fundaciones Independientes de Asistencia al Copago
Si necesita ayuda con el copago de RITUXAN, RITUXAN Access Solutions puede derivarle a una fundación independiente de asistencia al copago.
Una fundación independiente de asistencia al copago es una
organización benéfica que proporciona asistencia financiera para
medicamentos.
Llame a RITUXAN Access Solutions en el (888) 249-4918 para que le deriven.
Si desea ponerse en contacto directamente con una fundación, puede usar la información que se indica a continuación:
Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
La fundaciones independientes de asistencia al copago tienen sus
propias normas para elegibilidad. No podemos garantizarle que una
fundación le vaya a ayudar. Solo podemos derivarle para que esta le
asista con su estado de salud. Esta información solo se la
proporcionamos a modo informativo. No respaldamos ni mostramos
preferencia económica por ninguna fundación en particular. Las
fundaciones de esta lista no son las únicas que pueden ayudarle.
Derivaciones a la fundación Genentech Patient Foundation
La fundación Genentech® Access to Care Foundation ahora es Genentech Patient Foundation.
Aún nos enfocamos en proporcionar medicamentos gratuitos a los pacientes necesitados, pero hemos realizado algunos cambios para ofrecer mejor asistencia a más pacientes, más rápido.
Genentech Patient Foundation proporciona medicamentos gratuitos a las personas:
- Que no tienen seguro
- Cuyo tratamiento no está cubierto por el seguro
- Que tienen dificultades con sus elevados costos que deben abonar de su bolsillo
Para obtener más información y solicitar ayuda, visite GenentechPatientFoundation.com.
Si cuenta con cobertura de un seguro médico para su medicamento, primero debe haber probado otros tipos de asistencia a pacientes para ser apto para recibir RITUXAN gratis a través de la Genentech Patient Foundation. Esto incluye la Tarjeta de Copago de Genentech BioOncology y la ayuda de fundaciones independientes de asistencia al copago. También debe cumplir otros criterios financieros. Si no tiene seguro o si su seguro no cubre su medicamento, debe cumplir unos criterios financieros diferentes.
Derivaciones a la Tarjeta de Copago de Genentech BioOncology
RITUXAN Access Solutions puede derivarle a la Tarjeta de Copago de Genentech BioOncology. Si usted es elegible, puede ayudarle con los gastos de RITUXAN que deba abonar de su bolsillo.
La Tarjeta de Copago de Genentech BioOncology ayuda a los pacientes
con un seguro médico comercial. Puede que sea un plan que obtiene a
través de su empleador o uno que haya contratado en un Mercado de
Seguros Médicos como HealthCare.gov. Para poder calificar, también
debe cumplir otros criterios.
Para poder optar a la Tarjeta de Copago de Genentech BioOncology,
el paciente debe disponer de un seguro comercial, no debe tener
Medicare, Medicaid ni ningún otro seguro público y debe cumplir
otros criterios de elegibilidad. También debe aceptar las reglas
establecidas en los términos y condiciones del programa. Visite CopayAssistanceNow.com para ver la lista
completa de términos y condiciones.
Cómo Trabajar con RITUXAN Access Solutions
Paso 2
Trabajamos con usted, con la consulta de su médico, su plan de seguro médico y su farmacia especializada. Podríamos ponernos en contacto con usted para recabar más información.
PAN=siglas en inglés de Autorización del Paciente
y Aviso de Solicitud Para Transmitir Información Médica a Genentech
Access Solutions y a Genentech® Access to Care Foundation.
SMN=siglas en inglés de Declaración de Necesidad Médica.
Important Safety Information & Indication
What it Treats
RITUXAN® (Rituximab) is indicated for the treatment of:
- Low-grade or follicular CD20-positive non-Hodgkin’s lymphoma as a single-agent therapy in patients whose disease recurred or did not respond to initial treatment
- Follicular CD20-positive non-Hodgkin’s lymphoma as an initial treatment with chemotherapy, and in patients whose initial treatment was successful, as a single- agent follow-up therapy
- Low-grade CD20-positive non-Hodgkin’s lymphoma as a single-agent follow-up therapy for patients who did not progress on initial treatment with CVP chemotherapy
- CD20-positive diffuse large B-cell non-Hodgkin’s lymphoma as an initial treatment in combination with CHOP chemotherapy
- CD20-positive chronic lymphocytic leukemia in combination with FC chemotherapy as an initial treatment or as a treatment after disease has recurred
People with serious infections should not receive RITUXAN.
It is not known if RITUXAN is safe or effective in children.
Important Safety Information
What is the most important information I should know about RITUXAN?
Tell your doctor right away about any side effect you experience. RITUXAN can cause serious side effects that can lead to death, including:
- Infusion Reactions: may occur during or within 24 hours of your infusion. Your doctor should give you medicines before your treatment. Symptoms can include hives, rash, itching, facial or oral swelling, sudden cough, shortness of breath, difficulty breathing, weakness, dizziness, feeling faint, racing heart, or chest pain
- Severe Skin and Mouth Reactions: symptoms can include painful sores, ulcers, or blisters on your skin, lips or mouth; peeling skin; rash; or pustules
- Hepatitis B Virus (HBV) Reactivation: may cause serious liver problems including liver failure and death. If you have had hepatitis B or are a carrier of HBV, receiving RITUXAN could cause the virus to become an active infection again. You should not receive RITUXAN if you have active HBV liver disease. Your doctor will do blood tests to check for HBV infection prior to treatment and will monitor you during and for several months following your treatment
- Progressive Multifocal Leukoencephalopathy (PML): a rare, serious brain infection that can lead to severe disability and death and for which there is no known prevention, treatment, or cure. Symptoms can include difficulty thinking, loss of balance, changes in speech or walking, weakness on one side of your body, or blurred or lost vision
What are the additional possible serious side effects of RITUXAN?
Tell your doctor right away about any side effect you experience. RITUXAN can cause serious side effects that can lead to death, including:
- Tumor Lysis Syndrome (TLS): may cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, and can lead to death. Your doctor may give you medicines before your treatment to help prevent TLS
- Serious Infections: can happen during and after treatment and can lead to death.
These infections may be bacterial, fungal, or viral. Symptoms can include fever; cold or flu symptoms; earache or headache; pain during urination; white patches in the mouth or throat; cuts or scrapes that are red, warm, swollen, or painful - Heart Problems: symptoms can include chest pain and irregular heartbeats that may require treatment. Your doctor may need to stop your treatment
- Kidney Problems: your doctor should do blood tests to check how well your kidneys are working
- Stomach and Serious Bowel Problems: can include blockage or tears in the bowel that can lead to death. Stomach area pain during treatment can be a symptom
- Low Blood Cell Counts: your blood cell counts may be monitored during treatment
The most common side effects of RITUXAN are infusion reactions, chills, infections, body aches, tiredness, and low white blood cells.
Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is not known if RITUXAN may harm your unborn baby or pass into your breast milk. Women should use birth control while using RITUXAN and for 12 months after treatment.
Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects of RITUXAN. For more information, ask your doctor or pharmacist.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835- 2555.
Please see the RITUXAN full Prescribing Information, including the Medication Guide, for additional Important Safety Information.